Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Leukapheresis Device Market Evolve in Terms of Growth and Size by 2029?

The market size for leukapheresis devices has significantly expanded in the past few years. The market will escalate from $0.65 billion in 2024 to $0.70 billion in 2025, with a compound annual growth rate (CAGR) of 7.7%. Factors driving growth in the historical period include the surging demand for personalized medicine, an enhanced emphasis on research and development, an increase in clinical trials, a growing elderly population, and a rising preference for minimally invasive procedures.

In the forthcoming years, the leukapheresis device market is poised for robust expansion. By 2029, it is projected to reach $0.94 billion, with a compound annual growth rate (CAGR) of 7.5%. This predicted surge in the projection period can be ascribed to the escalating prevalence of blood-associated disorders, increasing cancer incidences, the surging demand for peripheral blood stem cell collection, the expanding utilization of leukapheresis in cellular therapies, and escalating investment in regenerative medicine and immunotherapy. Key trends for the projection period encompass advancements in apheresis device technology, the incorporation of automation and digital interfaces, progress in point-of-care leukapheresis technology, advancements in closed-loop leukapheresis systems, and technological enhancements in cell separation efficiency.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25807&type=smp

What factors are expected to fuel Leukapheresis Device market growth in the coming years?

The leukapheresis device market is poised for growth due to the increasing cases of diseases related to blood. These disorders affect the formation or operation of blood cells, which can lead to issues with blood clotting, immune response, or oxygen transport. A rise in these disorders is predominantly ascribed to the aging population who are at a higher risk of conditions like leukemia, anemia, and other hematological conditions. Leukapheresis devices offer help in managing these disorders by selectively removing surplus or abnormal white blood cells from the blood, thereby easing symptoms and reducing complications in diseases such as leukemia and autoimmune disorders. For example, the Leukaemia Foundation, an Australian non-profit organization, reported in May 2024 that around 19,403 Australians were diagnosed with blood cancers such as leukemia, lymphoma, or myeloma in 2022, which translates to an average of 53 cases each day, or one every 27 minutes. Currently, about 135,000 Australians are living with a blood cancer or disorder, a number that is expected to reach over 275,000 by 2035. Hence, the increasing instances of diseases related to blood are accelerating the expansion of the leukapheresis device market.

What Are The Key Findings From The Segmentation Analysis Of The Leukapheresis Device Market?

The leukapheresis device market covered in this report is segmented –

1) By Device Type: Therapeutic Leukapheresis, Cytapheresis, Stem Cell Collection, Research Applications, Leukapheresis Columns and Cell Separators, Leukapheresis Disposables, Apheresis Devices

2) By Component: Leukapheresis Machine, Blood Collection Set , Medical Consumables , Filters

3) By End User: Hospitals, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Blood Component Providers, Blood Centers

Subsegments:

1) By Therapeutic Leukapheresis: Leukemia Treatment Systems, Sepsis Treatment Leukapheresis Units, Autoimmune Disease Management Devices

2) By Cytapheresis: Plateletpheresis Devices, Lymphapheresis Units, Erythrocytapheresis Systems

3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices, Umbilical Cord Blood Collection Systems, Bone Marrow Stem Cell Apheresis Systems

4) By Research Applications: Cell Separation Systems for Research and Development, Clinical Trial Apheresis Platforms, Academic Laboratory Leukapheresis Devices

5) By Leukapheresis Columns And Cell Separators: Adsorption Columns, Membrane-Based Cell Separation Systems, Centrifugal Cell Separators

6) By Leukapheresis Disposables: Tubing Sets, Needles And Catheters, Collection Bags

7) By Apheresis Devices: Continuous Flow Apheresis Machines, Portable Or Mobile Apheresis Units, Intermittent Flow Apheresis Systems

Which Trends Are Expected To Shape The Future Of The Leukapheresis Device Market?

Leading firms in the leukapheresis device market are concentrating their efforts on increasing their manufacturing capabilities in local regions to promote national health goals and provide better access to high caliber therapeutic devices. The investment in regional production aids in the establishment of supply chains that are both effective and adaptable. This, in turn, guarantees punctual deliveries, lowers reliance on imports, and makes advanced cell and blood collection systems more affordable. In November 2024, as a case in point, the US-based medical tech firm, Terumo Blood and Cell Technologies, forged a partnership with Terumo Medical Products (Hangzhou) Co., Ltd., a subsidiary in China, to commence local production in Hangzhou. This tactical move includes the local production of essential leukapheresis products such as the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, which are widely utilized in China for therapeutic apheresis, stem cell gathering, and blood component separation.

What Are The Most Active Companies In The Leukapheresis Device Market Today?

Major companies operating in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Charles River Laboratories International Inc., Mallinckrodt Pharmaceuticals, Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, Precision for Medicine Inc., B. Braun Melsungen AG, BioIVT LLC, AllCells LLC, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd., Puriblood Medical Co. Ltd, Medica S.p.A.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report

Which Regional Markets Are Attracting The Most Investment In Leukapheresis Device?

North America was the largest region in the leukapheresis device market in 2024. The regions covered in the leukapheresis device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25807&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model